131 related articles for article (PubMed ID: 2127684)
1. [Pharmacologic profile of protirelin tartrate].
Angelucci L; Lorentz G; Maccari S; Patacchioli FR; Scaccianoce S; Taglialatela G
Ann Ital Med Int; 1990; 5(3 Pt 2):232-44. PubMed ID: 2127684
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of action of protirelin tartrate (TRH-T) on spinal motor neurons].
Nistri A
Ann Ital Med Int; 1990; 5(3 Pt 2):245-8. PubMed ID: 2127685
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the anxiolytic-like effect of TRH and the response of amygdalar TRHergic neurons in anxiety.
Gutiérrez-Mariscal M; de Gortari P; López-Rubalcava C; Martínez A; Joseph-Bravo P
Psychoneuroendocrinology; 2008 Feb; 33(2):198-213. PubMed ID: 18079066
[TBL] [Abstract][Full Text] [Related]
4. The TRH neuron: a hypothalamic integrator of energy metabolism.
Lechan RM; Fekete C
Prog Brain Res; 2006; 153():209-35. PubMed ID: 16876577
[TBL] [Abstract][Full Text] [Related]
5. Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats.
Heuer H; Schäfer MK; O'Donnell D; Walker P; Bauer K
J Comp Neurol; 2000 Dec; 428(2):319-36. PubMed ID: 11064370
[TBL] [Abstract][Full Text] [Related]
6. Pyroglutamyl peptidase II inhibition enhances the analeptic effect of thyrotropin-releasing hormone in the rat medial septum.
Lazcano I; Uribe RM; Martínez-Chávez E; Vargas MA; Matziari M; Joseph-Bravo P; Charli JL
J Pharmacol Exp Ther; 2012 Jul; 342(1):222-31. PubMed ID: 22532627
[TBL] [Abstract][Full Text] [Related]
7. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
8. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
[TBL] [Abstract][Full Text] [Related]
9. The serotoninergic bulbospinal system and brainstem-spinal cord content of serotonin-, TRH-, and substance P-like immunoreactivity in the aged rat with special reference to the spinal cord motor nucleus.
Johnson H; Ulfhake B; Dagerlind A; Bennett GW; Fone KC; Hökfelt T
Synapse; 1993 Sep; 15(1):63-89. PubMed ID: 7508641
[TBL] [Abstract][Full Text] [Related]
10. [Role of the neurohypophysis in psychological stress].
Scantamburlo G; Ansseau M; Legros JJ
Encephale; 2001; 27(3):245-59. PubMed ID: 11488255
[TBL] [Abstract][Full Text] [Related]
11. New data on the immunocytochemical localization of thyrotropin-releasing hormone in the rat central nervous system.
Merchenthaler I; Csernus V; Csontos C; Petrusz P; Mess B
Am J Anat; 1988 Apr; 181(4):359-76. PubMed ID: 3133939
[TBL] [Abstract][Full Text] [Related]
12. Central administration of cocaine- and amphetamine-regulated transcript increases phosphorylation of cAMP response element binding protein in corticotropin-releasing hormone-producing neurons but not in prothyrotropin-releasing hormone-producing neurons in the hypothalamic paraventricular nucleus.
Sarkar S; Wittmann G; Fekete C; Lechan RM
Brain Res; 2004 Mar; 999(2):181-92. PubMed ID: 14759497
[TBL] [Abstract][Full Text] [Related]
13. [Use of TRH-T for the symptomatic treatment of the pathology of the upper motoneurons and electrophysiologic evaluation of its efficacy].
Martinelli P
Ann Ital Med Int; 1990; 5(3 Pt 2):262-9. PubMed ID: 2127688
[TBL] [Abstract][Full Text] [Related]
14. The stress system in the human brain in depression and neurodegeneration.
Swaab DF; Bao AM; Lucassen PJ
Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin releasing hormone-induced potentiation of spinal monosynaptic reflex in rats in vitro.
Deshpande SB; Warnick JE
Indian J Exp Biol; 1993 Feb; 31(2):112-5. PubMed ID: 8500826
[TBL] [Abstract][Full Text] [Related]
16. Effects of the novel thyrotropin-releasing hormone analogue Na -((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prol ina mide monohydrate on the central nervous system in mice and rats.
Matsushita M; Yonemori F; Furukawa N; Ohta A; Toide K; Uchida I; Iwata K
Arzneimittelforschung; 1993 Aug; 43(8):813-7. PubMed ID: 8216433
[TBL] [Abstract][Full Text] [Related]
17. The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics.
Gary KA; Sevarino KA; Yarbrough GG; Prange AJ; Winokur A
J Pharmacol Exp Ther; 2003 May; 305(2):410-6. PubMed ID: 12606661
[TBL] [Abstract][Full Text] [Related]
18. [The effect of thyrotropin-releasing hormone on the activity of the septal neurons in brain slices from hibernating and active susliks Citellus undulatus].
Belousov AB; Belousova ZhV
Zh Evol Biokhim Fiziol; 1993; 29(2):159-66. PubMed ID: 8317180
[TBL] [Abstract][Full Text] [Related]
19. Novel thyrotropin-releasing hormone analogs: a patent review.
Khomane KS; Meena CL; Jain R; Bansal AK
Expert Opin Ther Pat; 2011 Nov; 21(11):1673-91. PubMed ID: 22017410
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine implications for the association between cocaine- and amphetamine regulated transcript (CART) and hypophysiotropic thyrotropin-releasing hormone (TRH).
Fekete C; Lechan RM
Peptides; 2006 Aug; 27(8):2012-8. PubMed ID: 16730860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
